Trastuzumab in CNS progressive metastatic breast cancer

Author： Tosoni Alicia   Franceschi Enrico   Esposti Roberta Degli   A Brandes Alba  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.3, Iss.4, 2007-08, pp. : 367-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ongoing trials with trastuzumab in metastatic breast cancer

By Bell R.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 69-73

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on Trastuzumab in Metastatic Breast Cancer Overexpressing HER2

By McKeage K.   Perry C.M.  

American Journal of Cancer, Vol. 1, Iss. 3, 2002-03 ,pp. : 217-221

Adis International

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer

By Lidgren Mathias   Wilking Nils   Jonsson Bengt   Rehnberg Clas  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1018-1028

Informa Healthcare

Access to resources Recommend Favorite

Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer

By Keck Sara   Glencer Alexa C   Rugo Hope S  

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1383-1396

Future Medicine

Access to resources Recommend Favorite